← Back to all trials
Not Yet Recruiting
NCT07732686
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Conditions: Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon Cancer, Bladder Cancer, Other Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 2000
Sponsor: University of Oklahoma
Location: OU Health Stephenson Cancer Center Oklahoma City Oklahoma
Summary
The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 at the time of consent. Male and female patients to be tested.
* Capable of understanding written and/or spoken English language.
* Able to provide informed consent.
* Cancer of any type.
* Newly diagnosed cancer and untreated or established diagnosis of cancer. For established cancer patients, no active anti-cancer treatment for more than one month (reasons for no treatment are such as relapse, progression of cancer, refractory, or intolerance to treatment etc.)
Exclusion Criteria:
* Under the age of 18.
* Anticipated inability to complete breath sampling procedure.
* Unable to provide informed consent.
* Pregnant women
* Active respiratory infection symptoms
* Recent use of antibiotics
* Difficulty in performing coached exhalation
* Individuals who are unable to follow the instructions
* Cancer patients who are on active treatment for cancer or have received cancer treatment within one month
Source: ClinicalTrials.gov (NCT07732686). StuddyBuddy aggregates publicly available trial information.
